Director, Stem Cell Transplant Job at HealthEcareers - Client in Los Angeles Cou

The Director of the IUO will provide visionary leadership to advance clinical care, research, and education in urologic cancers. Reporting to the Chair of the Department of Urology and the Executive Committee of the IUO, this role is responsible for shaping the strategic direction of the institute, fostering interdisciplinary collaboration, and driving innovation in patient-centered oncology services. The Director will serve as a key departmental and institutional leader, promoting excellence in academic and translational research, oversee clinical trials, mentor faculty and trainees, and expand the institute’s scope and reputation. Established in 2014, the IUO is a comprehensive multi-disciplinary home for high-volume urologic oncologists with collaborative basic and translational research, and a track record of innovative and practice-changing clinical trials. Endowed with funds to support its mission, the new Director will have resources available for development of new programs and hiring of key scientists and clinicians. Responsibilities • Lead strategic planning and program development for the IUO. • Oversee clinical operations, ensuring high-quality, innovative, evidence-based care across all urologic cancer services. • Promote and support collaborations and partnerships with Medical Oncology, Radiation Oncology, Nuclear Medicine, basic research initiatives, the Jonsson Comprehensive Cancer center (JCCC), including clinical trials, translational science, and outcomes research. • Re-establish a working multi-disciplinary Board of Directors for the IUO and supervise regular quarterly meetings. Inaugurate a board of “Friends of IUO”. • Recruit and mentor faculty, trainees, and staff to build a dynamic and inclusive academic environment. • Cultivate philanthropic and industry partnerships to support growth, scholarship, and innovation. • Represent the institute in institutional, national, and international forums. • Create active collaboration with the newly established multidisciplinary California Institute of Immunology and Immunotherapy (CIII), in affiliation with UCLA Health. Qualifications • MD, MD/PhD, or equivalent with board certification in Urology and fellowship training in Urologic Oncology. • Academic rank of Associate Professor or Professor. • Demonstrated success in clinical, research, and educational domains. • Proven track record of program development, team building, collaboration and strategic execution. • Strong interpersonal and communication skills Appointment Details This is a full-time faculty leadership position with rank and compensation commensurate with experience. The Director will maintain clinical, research, and teaching responsibilities in alignment with institutional goals. The candidate will be considered for The Spielberg Family Chair in Urologic Oncology • For the tenured position, apply via UC Recruit at: https://recruit.apo.ucla.edu/JPF10718 • For the non-tenured track position apply via UC Recruit at: https://recruit.apo.ucla.edu/JPF10717 The shared values of the DGSOM are expressed in the Cultural North Star, which was developed by members of our community and affirms our unswerving commitment to doing what’s right, making things better, and being kind. These are the standards to which we hold ourselves, and one another. Please read more about this important DGSOM program at https://medschool.ucla.edu/cultural-north-star . All aspects of searches are confidential and all candidates are expected to review and abide by UC Regents Policy 1111 on Statement on Ethical Values and Standards of Conduct [ https://regents.universityofcalifornia.edu/governance/policies/1111.html ] The University of California is committed to creating and maintaining a community dedicated to the advancement, application, and transmission of knowledge and creative endeavors through academic excellence, where all individuals who participate in University programs and activities can work and learn together in a safe and secure environment, free of violence, harassment, bullying and other demeaning behavior, discrimination, exploitation, or intimidation. With this commitment as well as a commitment to addressing all forms of academic misconduct, UCLA conducts targeted employment reference checks for finalists to whom departments or other hiring units would like to extend formal offers of appointment into Academic Senate faculty positions. The targeted employment reference checks involve contacting the finalists’ current and prior places of employment to ask whether there have been substantiated findings of misconduct that would violate the University’s Faculty Code of Conduct. To implement this process, UCLA requires all applicants for Academic Senate faculty positions to complete, sign, and upload the form entitled “Authorization to Release Information” into RECRUIT as part of their application. If the applicant does not include the signed authorization to release information with the application materials, the application will be considered incomplete. As with any incomplete application, the application will not receive further consideration. Although all applicants for faculty recruitments must complete the entire application, only finalists (i.e., those to whom the department or other hiring unit would like to extend a formal offer) considered for Academic Senate faculty positions will be subject to targeted employment reference checks. As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements. The University of California is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected status under state or federal law. As a condition of employment, the finalist will be required to disclose if they are subject to any final administrative or judicial decisions within the last seven years determining that they committed any misconduct, are currently being investigated for misconduct, left a position during an investigation for alleged misconduct, or have filed an appeal with a previous employer. • “Misconduct” means any violation of the policies or laws governing conduct at the applicant’s previous place of employment, including, but not limited to, violations of policies or laws prohibiting sexual harassment, sexual assault, or other forms of harassment, discrimination, dishonesty, or unethical conduct, as defined by the employer. • https://policy.ucop.edu/doc/4000385/SVSH • https://policy.ucop.edu/doc/1001004/Anti-Discrimination • https://www.ucop.edu/academic-personnel-programs/_files/apm/apm-035.pdf In Summary: The Division of Cancer Medicine at the Banner MD Anderson Cancer Center (BMDACC) in metro Phoenix, Arizona is actively seeking a Director of Stem Cell Transplantation (SCT) The program is FACT-accredited in autologous, allogeneic, and immune effector cell therapy and includes seven current faculty members . In 2025, the program performed 160 cellular therapy procedures . En Español: La División de Medicina del Cáncer en el Banner MD Anderson Cancer Center (BMDACC) en Phoenix, Arizona está buscando activamente a un Director de Transplante de Células Madres (SCT), que proporcionará liderazgo para apoyar el crecimiento programático continuo y la mejora de calidad para el programa de Transplantes de Célula Madre. Las responsabilidades clave incluyen dirigir un equipo multidisciplinario de expertos en hematología y trasplante de células madre, administrar ensayos clínicos continuos e investigaciones en regímenes innovadores de trasplantes y nuevas terapias investigativas, supervisar a un equipo que se esfuerce por una atención al paciente basada en la evidencia e individualizada, y asesorar a estudiantes de medicina, residentes y becarios, brindando capacitación en transplantes de células madres y terapias celulares. Este individuo también ayudará a supervisar las rotaciones del SCT y el circuito profesional para nuestro programa de beca de Hematología/Oncología de la Universidad de Arizona. El candidato exitoso tendrá un doctorado, MD / PhD o DO de una escuela médica acreditada, será certificado / junta elegible en Hematología / Oncología y será elegible para obtener licencia médica en el estado de Arizona . Deben tener una experiencia mínima de 3 a 5 años con terapia celular y liderazgo de calidad en investigación clínica y trayectoria Celular Transplantal, como prueba de pasión en pruebas clínicas y traducción de células sanguíneas y deben ser certificados por un registro de excelencia en estudios clínico y una formación sobre la calidad de referencia clínica. Desde 2011, Banner Health y The University of Texas MD Anderson Cancer Center se han asociado para proporcionar a los pacientes tecnología de última generación para el diagnóstico, estadificación y tratamiento de todos los tipos de cáncer; experiencia en oncología en servicios de atención de apoyo; y acceso a ensayos clínicos innovadores y nuevas terapias investigativas. Juntos, nuestros especialistas específicos de enfermedades adoptan un enfoque multidisciplinario para brindar una atención excepcional centrada en el paciente en las instalaciones. Nuestra asociación trae oportunidades educativas sin precedentes al área de la salud. Además del programa de asistencia sanitaria Banner ofrece múltiples beneficios académicos e incentivos superiores a muchos empleados, además de una amplia calificación educativa superior. Banner Health prohíbe la discriminación en base a raza, color, religión, sexo (incluyendo embarazo), orientación sexual, identidad de género, información genética, origen nacional, edad, discapacidad, estado civil, estatus familiar, condición de ciudadanía u otra clasificación protegida. Esta prohibición incluye el acoso basado en cualquiera de las clasificaciones protegidas mencionadas anteriormente, incluyendo acoso sexual y mala conducta sexual.